Citriodiol in insect repellent may protect against COVID-19: UK study


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Citriodiol in insect repellent may protect against COVID-19: UK study
Citriodiol had anti-viral properties if mixed with the virus in the liquid phase and on a test surface

Citriodiol, an ingredient found in insect repellant, may kill novel coronavirus, according to British researchers. The ingredient extrapolated from the eucalyptus citriodora tree was studied for its use as a protective layer against SARS-CoV-2 by the UK’s military, according to a release by the Ministry of Defense.

The team of researchers out of the UK’s Defence Science and Technology Laboratory (Dstl) investigated the antiviral properties of Citriodiol against coronavirus by using a mosquito repellant, Mosi-guard, which contains Citriodiol as an active ingredient, the release stated. The insect repellant was applied to a liquid drop of the virus and then to a synthetic skin made of latex.

Citriodiol, an ingredient found in insect repellant, may kill the novel coronavirus, according to British researchers. (iStock)“One minute liquid suspension tests indicated that Mosi-guard Natural has anti-viral activity against SARS-CoV-2  isolate if mixed with the virus in the liquid phase. Additionally, viral studies on latex indicated that Mosi-guard Natural had antiviral activity against SARS-CoV-2 England-2 isolate," the UK report stated.

Back in May, UK Defense Secretary Ben Wallace confirmed that the British Armed Forces were using the insect repellant on a precautionary level as another potential layer of protection against the novel coronavirus, which was based on the advice of the UK surgeon general, who said it was unlikely to be harmful, according to an article in Science Focus.

“We are very excited by these findings and have several new studies either already going through laboratories or planned," Jacqueline Watson, managing director of Cetrifine, which produces Citriodiol, stated in a release on the company’s website.

The researchers stated in the report that “this research paper demonstrates preliminary findings on the effectiveness of Citriodiol against COVID-19.”

Dstl is hopeful that the findings in this research can be used as a springboard for other organizations to expand and develop the research, as well as to confirm the findings in this publication," the study authors added.

Citriodiol is approved by the U.S. Environmental Protection Agency (EPA) and recommended by the U.S. Centers for Disease Control and Prevention (CDC) for use against mosquito bites, which can ultimately help to prevent the spread of mosquito-borne diseases.

Tags : #Citriodol #Antiviral #UKStudy #LatestCovidNewsUpdateAug29 #EPA #DSTL #CDC #BenWallace

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Tier-2 and Tier-3 Cities: India's Next Big Healthcare Growth StorySeptember 18, 2026
Why Regional Hospital Chains Are Becoming More Important in IndiaSeptember 18, 2026
The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026